跳至主要内容
临床试验/NCT05673681
NCT05673681招募中不适用

Registro de Melanoma de la AEDV

Fundación Academia Española de Dermatología21 个研究点 分布在 1 个国家目标入组 7,000 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
7,000
试验地点
21
主要终点
AJCC (American Joint Committee on Cancer) TNM stage (Tumor, node, metastasis)

研究概览

简要总结

The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are:

  • To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level.
  • To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres.

排除标准

  • In-situ melanomas
  • non-cutaneous melanomas,
  • metastatic melanoma with unknown primary site.

结局指标

主要结局

AJCC (American Joint Committee on Cancer) TNM stage (Tumor, node, metastasis)

时间窗: 1 day At diagnosis

Staging based on tumor thickness and ulceration, spread to lymph nodes and spread to distant sites.

Breslow thickness

时间窗: 1 day At diagnosis

Breslow thickness is the measurement of the depth of the melanoma from the surface of your skin down through to the deepest point of the tumour.

次要结局

  • Time to progression(through study completion, an average of 3 years)
  • Survival(through study completion, an average of 3 years)

研究者

发起方
Fundación Academia Española de Dermatología
申办方类型
Other
责任方
Sponsor

研究点 (21)

Loading locations...

相似试验